TRIGENESIS
DEAD

Serial Number

90369578

Owner

SAREPTA THERAPEUTICS, INC.

Attorney

Paul C. Llewellyn

Filing Date

Dec 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

TRIGENESIS Trademark

Serial Number: 90369578

TRIGENESIS is a trademark filed by SAREPTA THERAPEUTICS, INC. on December 9, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently no longer active.

Owner Contact Info

SAREPTA THERAPEUTICS, INC. (109 trademarks)

215 FIRST STREET, SUITE 7
CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

December 9, 2020

Registration Date

Not Registered

Published for Opposition

February 8, 2022

Goods & Services

Printed materials, namely, brochures, leaflets, reports, and newsletters on the topics of medicine, medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, rare diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, genetic therapy research, and diagnosis and treatment of genetic disorders

Medical information services, namely, providing information relating to medicine, rare diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and diagnosis and treatment of genetic disorders; Providing medical information via a website in the field of medicine, diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and diagnosis and treatment of genetic disorders; Providing medical information to doctors and patients regarding rare diseases, medicines, health conditions and treatment options

Medical research; medical and scientific research services all in the field of rare diseases; medical and scientific research services all in the field of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, and genetic diseases and disorders; medical and scientific research services all in the field of gene therapy, gene editing, genome editing, viruses, viral vectors, and viral constructs; providing information relating to medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, and medical research in the field of genetic therapy; providing information via a website in the field of medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, and medical research in the field of genetic therapy

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 7, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 7, 2022 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 5, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 19, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 4, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 4, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 4, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 4, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 2, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 2, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 2, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jun 2, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jun 2, 2021 CNRT
ASSIGNED TO EXAMINER
May 29, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 17, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 16, 2021 NWOS
NEW APPLICATION ENTERED
Dec 12, 2020 NWAP